Gallbladder Cancer clinical trials

Explore recruiting gallbladder cancer clinical trials.

Recruiting gallbladder cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gallbladder Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label Early Access Phase 3b Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Netherlands, Austria, Germany, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label Early Access Phase 3b Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Germany, Sweden, Netherlands, Austria, Italy, Spain +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours

Spain, France, Belgium, Germany, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label randomized trial of the efficacy and safety of zanidatamab with standard-of-care therapy against standard of-care therapy alone for advanced HER2 positive biliary tract cancer

Germany, Belgium, Spain, Finland, Czechia, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)

Norway, Italy, Poland, Spain, Belgium, Denmark +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary)

Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Gallbladder Cancer trials by city

Gallbladder Cancer in Toronto Gallbladder Cancer in Vancouver Gallbladder Cancer in Montreal Gallbladder Cancer in Calgary Gallbladder Cancer in Edmonton Gallbladder Cancer in Ottawa Gallbladder Cancer in Winnipeg Gallbladder Cancer in Quebec City Gallbladder Cancer in Hamilton Gallbladder Cancer in Kitchener Gallbladder Cancer in London Gallbladder Cancer in Halifax Gallbladder Cancer in New York Gallbladder Cancer in Los Angeles Gallbladder Cancer in Chicago Gallbladder Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease